MYC and neoplasm: Stabilized YTHDF1 then binds to m6A-modified c-Myc mRNA and promotes its decay, thereby repressing c-Myc protein synthesis and its-driven glycolytic flux, which ultimately attenuates the anti-tumor T cell immune response209.